We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Action mechanism as a cause of chronic constipation of inhaled and intravenously injected polystyrene nanoplastics in ICR mice
Summary
Researchers found that ICR mice inhaling 500 nm polystyrene nanoplastics for two weeks developed significant constipation symptoms — reduced GI motility, altered mucin secretion, and enteric nervous system disruption — demonstrating that inhaled nanoplastics can affect gut function.
The inhalation effects of airborne nanoplastics (NPs) on the gastrointestinal (GI) tract are rarely investigated, with most studies focusing only on the lungs and other organs. This study examined the changes in the key constipation phenotypes, mucin secretion, water and ion balance, and enteric nervous system (ENS) function in ICR mice after inhalation of polystyrene (PS)-NPs with 500 nm size for two weeks to determine if inhaled NPs can cause constipation. Significant constipation phenotypes, including the weight, water contents and morphology of stools, GI motility, intestinal length, histopathological structure of the colon, and concentration of GI hormone, were detected in NPs-inhaled ICR mice compared to a Vehicle-treated group. In addition, NPs-induced defecation delay was accompanied by a decrease in mucin secretion, suppressed transcription of mucin-related genes, and abnormal regulation of the colonic fluid transport system, including water and ions. NPs-inhaled mice showed a decrease in the neuronal cell density and dysfunction of excitatory neurons and inhibitory neurons in the ENS of the colon. Moreover, similar phenotypes for constipation were verified in ICR mice injected intravenously with NPs. Therefore, these results provide the first scientific evidence that inhalation and intravenous injection of PS-NPs can be considered as one of novel causes of constipation.
Sign in to start a discussion.
More Papers Like This
Novel Characterization of Constipation Phenotypes in ICR Mice Orally Administrated with Polystyrene Microplastics
Researchers found that oral administration of 0.5 micrometer polystyrene microplastics to ICR mice for two weeks induced significant constipation-like phenotypes, including altered water consumption, reduced stool weight and water content, and changes in gastrointestinal transit markers. The study provides direct experimental evidence that microplastic ingestion can disrupt bowel function in mammals.
Polystyrene micro- and nanoplastics in a colitis mouse model – effects on biodistribution, macrophage polarization, and gut microbiome
Researchers exposed colitis mouse models to polystyrene micro- and nanoplastics to test whether MNP exposure worsens inflammatory bowel disease, finding that MNPs altered biodistribution and exacerbated inflammatory responses in animals with pre-existing gut inflammation.
Ingested nano- and microsized polystyrene particles surpass the intestinal barrier and accumulate in the body
Researchers fed mice nano- and microsized polystyrene particles for up to 24 weeks to study intestinal barrier crossing and accumulation. The study found that plastic particles accumulated in the small intestine and distant organs, though they did not promote intestinal inflammation or worsen colitis, while noting that long-term accumulative effects on gastrointestinal health cannot be ruled out.
In vivo impact assessment of orally administered polystyrene nanoplastics: biodistribution, toxicity, and inflammatory response in mice
Researchers orally administered polystyrene nanoplastics to mice for two weeks and tracked their distribution and biological effects. The nanoplastics accumulated primarily in the intestine, kidneys, and liver, triggering significant inflammatory responses and oxidative stress in these organs despite no visible tissue damage. The study provides evidence that even short-term oral exposure to nanoplastics can cause meaningful inflammatory changes in multiple organ systems.
Nanoplastics as a potential environmental health factor: effects of polystyrene nanoparticles on human intestinal epithelial Caco-2 cells
Researchers tested how polystyrene nanoparticles interact with human intestinal cells in the lab. They found that the nanoparticles were readily taken up by the cells in a concentration-dependent manner, but no significant toxic effects were observed under the conditions tested. The study suggests that while nanoplastics can enter gut cells, their short-term toxicity at the tested levels appears limited.